BGM
Bgm Group Ltd
NASDAQ · Pharmaceuticals
$1.14
-0.08 (-6.56%)
Open$1.33
Previous Close$1.22
Day High$1.41
Day Low$1.11
52W High$9.12
52W Low$4.81
Volume—
Avg Volume239.8K
Market Cap209.71M
P/E Ratio16.43
EPS$0.38
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 101.37M | 106.35M | 109.96M |
| Net Income | 12.48M | 12.42M | 13.50M |
| Profit Margin | 12.3% | 11.7% | 12.3% |
| EBITDA | 20.71M | 22.69M | 21.79M |
| Free Cash Flow | 8.96M | 8.29M | 10.61M |
| Rev Growth | +16.4% | +7.5% | +6.8% |
| Debt/Equity | 0.21 | 0.19 | 0.22 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |